• Home
  • NEW DAY MEDICINE
  • 4(32)2020
  • 14 -4 (32/1)2020 — Saydaliev S.B., Raximbaeva G.S. — CLINICAL AND NEUROLOGICAL FEATURES OF THE ISCHEMIC STROKE IN COVID-19, OPTIMIZATION OF THERAPEUTIC APPROACHES

14 -4 (32/1)2020 — Saydaliev S.B., Raximbaeva G.S. — CLINICAL AND NEUROLOGICAL FEATURES OF THE ISCHEMIC STROKE IN COVID-19, OPTIMIZATION OF THERAPEUTIC APPROACHES

CLINICAL AND NEUROLOGICAL FEATURES OF THE ISCHEMIC STROKE IN COVID-19,
OPTIMIZATION OF THERAPEUTIC APPROACHES

Saydaliev S.B. -Tashkent Medical Academy Fergana Branch

Raximbaeva G.S. -Tashkent Medical Academy Fergana Branch

Resume

The COVID-19 pandemic affecting all parts of the world is having huge implications for stroke care. Not only do stroke patients appear to be more susceptible to severe infection, but also the pandemic is having major implications on how we deliver stroke care. COVID-19 infection itself has also been described as a risk factor for stroke.

Key words: COVID-19, stroke, coagulopathy, D-dimer, SARS-CoV-2 virus, thromboprophylaxis.

First page

70

Last page

73

For citation: Saydaliev S.B., Raximbaeva G.S., Clinical and neurological features of the ischemic stroke in covid-19, optimization of therapeutic approaches//New Day in Medicine 4(32)2020 70-73 https://cutt.ly/Tl4dPAa

List of References

  1. 2020 Heart Disease and Stroke Statistical Update Fact Sheet At­a-Glance.
  2. https://www.researchgate.net/publication/327028621_Stroke_ types_and_management.
  3. A conceptual frameworks for the OECD Health Care Quality in Health Care /О.А Arah et al-September.2006// Suppl. 18,- P.5­14.
  4. Виберс, Д.О. Инсульт: климческое руководство Текст. / Д.О. Виберс
  5. Umapathi T, Kor AC, Venketasubramanian N, et al. Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).J Neurol2004; 251(10):1227-1231. doi:10.1007/s00415-004-0519-8 CrossRefPubMedGoogle Scholar
  6. A 24-week, double blind, place-bo-controlled study of cerebrolysin in patients whith mild to moderate Alzheimer disease /Х.А. Alvarez et al. // Eur J Neurol. -2006; 13:1: 43-54.
  7. Mao l., Jin h., Wang m. et.al. neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, china/
  8. Acute ischemic stroke and COVID-19 Catherine Hassett, DO, Aron Gedansky, MD, MaryAnn Mays, MD and Ken Uchino, MD Cleveland Clinic Journal of Medicine June 2020, DOI: https:/ /doi.org/10.3949/ccjm.87a.ccc042
  9. COVID-19-Related Stroke David C. Hess, Wael Eldahshan &Elizabeth RutkowskiTranslational Stroke Research volume 11, pages322-325(2020)
  10. Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J ThrombHaemost. 2019;17(11):1989-94. https://doi.org/10.1111/jth.14578.
  11. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J ThrombHaemost. 2020. https://doi.org/10.1111/jth.14817.
  12. World Health Organization. Coronavirus (COVID-2019) situation reports. Accessed June 15, 2020. https://www.who.int/ emergencies/diseases/novel-coronavirus-2019/situation-reports/
  13. Yaghi S, Ishida K, Torres J, et al. SARS2-CoV-2 and stroke in a New York healthcare system. Stroke. 2020; A120030335. doi:10.1161/ STROKEAHA.120.030335.
  14. Boehme A.K., Luna J., Kulick E.R., Kamel H., Elkind M.SV. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol. 2018;5(4):456-463. doi:10.1002/acn3.545
  15. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza Alexander E. Merkler, MD1; Neal S. Parikh, MD, MS1; Saad Mir, MD1; et al JAMA Neurol. Published online July 2, 2020. doi:10.1001/ jamaneurol.2020.2730
  16. A systematic review and meta-analysis of stroke in COVID-19 patients. Nannoni, S., et al. (2020) EXPRESS: Stroke in COVID- 19: a systematic review and meta-analysis. International Journal of Stroke. doi.org/10.1177/1747493020972922.
  17. Zucker d., Zucker b. hospital-based use of thromboprophylaxis in patients with covid-19 / published online april 21, 2020 https://doi.org/10.1016/s0140-6736(20)30926-0
  18. Cukera. Peyvandil coronavirus disease 2019 (covid-19): hypercoagulability/ this topic last up dated apr 29, 2020.
  19. Coronavirus disease 2019 (COVID-19): Hypercoagulability Adam Cuker, MD, MS, Flora Peyvandi, MD, PhD, Lawrence LK Leung, MDliterature review current through: Sep 2020. | This topic last updated Oct 12, 2020.
14-70-73-4-32-2020-тиббиёт-25-12-2020-—-копия

file

download